리라글루티드 시장 : 용도별, 유통별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Liraglutide Market size was valued at USD 8,982.34 Million in 2023, expanding at a CAGR of 11.34% from 2024 to 2032.

Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, serves as a treatment for type-2 diabetes and chronic obesity. It becomes necessary when diet and exercise alone fail to adequately control blood sugar levels. Typically employed as a second-line therapy for diabetes, following initial treatment with metformin, liraglutide is also utilized to mitigate the risk of heart and blood vessel complications, including heart attacks and strokes, in individuals with type-2 diabetes and pre-existing heart or blood vessel conditions. Marketed under the brand names Victoza and Saxenda, liraglutide addresses critical health concerns in diabetic and obese populations.

Liraglutide Market- Market Dynamics

Increasing awareness rates of obesity and sedentary lifestyles, to propel market demand

The Liraglutide for this market is expected to witness significant growth driven by escalating rates of obesity and sedentary lifestyles, which have led to a gradual increase in the diabetic population over time. Additionally, improper dietary habits and the underlying prevalence of diabetes disorders contribute to this trend. Furthermore, increased investment in research and development, coupled with technological advancements and the introduction of new products, present promising opportunities for the expansion of GLP-1 agonists in the market over the forecast period.

Liraglutide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.34% over the forecast period (2024-2032)

Based on distribution channel segmentation, retail pharmacies and drug stores was predicted to show maximum market share in the year 2023

Based on application segmentation, Diabetes Treatment was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Liraglutide Market- Segmentation Analysis:

The Global Liraglutide Market is segmented on the basis of Application, Distribution, and Region.

The market is divided into three categories based on distribution channel: Hospital Pharmacies, Retail Pharmacies & Drug Stores and Online Pharmacies. The dominant distribution channel is retail pharmacies and drug stores in 2023. This channel offers convenience and accessibility to patients seeking liraglutide, making it a popular choice for obtaining medications. While hospital pharmacies may play a significant role, especially for patients receiving treatment within hospital settings, the broader accessibility provided by retail pharmacies and drug stores often results in higher sales volume and market penetration. Online pharmacies may also contribute to distribution, particularly for patients preferring the convenience of online ordering and delivery. However, retail pharmacies and drug stores typically have a more established presence and may therefore hold a larger share of the market.

The market is divided into two categories based on application: Diabetes Treatment and Weight Management. Within the liraglutide market, the diabetes treatment holds a notable position in 2023. Liraglutide, a medication predominantly prescribed for managing type 2 diabetes, functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, effectively regulating blood sugar levels by stimulating insulin secretion, suppressing glucagon release, and delaying gastric emptying. Its effectiveness in glycemic control, combined with ancillary benefits such as weight reduction and mitigating cardiovascular risks, establishes liraglutide as a cornerstone therapy for diabetes management. As a result, the diabetes treatment segment experiences substantial demand from healthcare providers and patients striving to attain glycemic targets and mitigate the risk of diabetes-related complications effectively.

Liraglutide Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Liraglutide Market- Competitive Landscape:

In the Liraglutide market, companies are deploying varied strategies to address increasing demand and enhance patient outcomes. These strategies encompass ongoing research and development initiatives aimed at refining the formulation and delivery methods of liraglutide, with the goal of enhancing its effectiveness and improving patient convenience. Moreover, companies are allocating resources to conduct clinical trials to investigate new indications for liraglutide, such as its potential role in reducing cardiovascular risks and treating non-alcoholic fatty liver disease. Additionally, marketing efforts are focused on raising awareness among healthcare professionals and patients alike, aiming to foster broader adoption and market penetration.

Recent Developments:

In October 2023, Biocon, a global biopharmaceutical company, unveiled a collaboration with Juno Pharmaceuticals, a specialty pharmaceutical company headquartered in Canada, to commercialize Liraglutide, a drug-device combination designed for the treatment and management of type-2 diabetes and obesity within the Canadian market. Per the terms of the agreement, Biocon will undertake the responsibility of obtaining government approvals for Liraglutide and subsequently oversee its manufacturing and distribution throughout Canada.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIRAGLUTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Bachem

HEC Pharm

Kingpep Biotechnology

Shenzhen JYMed Technology

Novo Nordisk

Eli Lilly and Company

Boehringer Ingelheim

AstraZeneca

Others

GLOBAL LIRAGLUTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Diabetes Treatment
• Weight Management

GLOBAL LIRAGLUTIDE MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

GLOBAL LIRAGLUTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.Liraglutide Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.Liraglutide Market Snippet by Application
  • 2.1.2.Liraglutide Market Snippet by Distribution
  • 2.1.3.Liraglutide Market Snippet by Country
  • 2.1.4.Liraglutide Market Snippet by Region
• 2.2.Competitive Insights

3.Liraglutide Key Market Trends

• 3.1.Liraglutide Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.Liraglutide Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.Liraglutide Market Opportunities
• 3.4.Liraglutide Market Future Trends

4.Liraglutide Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.Liraglutide Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.Liraglutide Market Landscape

• 6.1.Liraglutide Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.Liraglutide Market - By Application

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 7.1.2.Diabetes Treatment
  • 7.1.3.Weight Management

8.Liraglutide Market - By Distribution

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By Distribution, 2023 & 2032 (%)
  • 8.1.2.Hospital Pharmacies
  • 8.1.3.Retail Pharmacies & Drug Stores
  • 8.1.4.Online Pharmacies

9.Liraglutide Market- By Geography

• 9.1.Introduction
  • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 9.2.North America
  • 9.2.1.Overview
  • 9.2.2.Liraglutide Key Manufacturers in North America
  • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.2.4.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.2.5.North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.2.6.U.S.
    • 9.2.6.1.Overview
    • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.6.3.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.4.U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.2.7.Canada
    • 9.2.7.1.Overview
    • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.7.3.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.4.Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
• 9.3.Europe
  • 9.3.1.Overview
  • 9.3.2.Liraglutide Key Manufacturers in Europe
  • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.3.4.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.5.Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.6.Germany
    • 9.3.6.1.Overview
    • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.6.3.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.4.Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.7.Italy
    • 9.3.7.1.Overview
    • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.7.3.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.4.Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.8.United Kingdom
    • 9.3.8.1.Overview
    • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.8.3.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.4.United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.9.France
    • 9.3.9.1.Overview
    • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.9.3.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.4.France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.10.Russia
    • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.10.2.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.3.Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.11.Netherlands
    • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.11.2.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.3.Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.12.Sweden
    • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.12.2.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.3.Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.13.Poland
    • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.13.2.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.3.Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.14.Rest of Europe
    • 9.3.14.1.Overview
    • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
• 9.4.Asia Pacific (APAC)
  • 9.4.1.Overview
  • 9.4.2.Liraglutide Key Manufacturers in Asia Pacific
  • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.4.4.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.5.Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.6.India
    • 9.4.6.1.Overview
    • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.6.3.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.4.India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.7.China
    • 9.4.7.1.Overview
    • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.7.3.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.4.China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.8.Japan
    • 9.4.8.1.Overview
    • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.8.3.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.4.Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.9.South Korea
    • 9.4.9.1.Overview
    • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.9.3.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.4.South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.10.Australia
    • 9.4.10.1.Overview
    • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.10.3.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.4.Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.11.Thailand
    • 9.4.11.1.Overview
    • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.11.3.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.4.Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.12.Indonesia
    • 9.4.12.1.Overview
    • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.12.3.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.4.Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.13.Philippines
    • 9.4.13.1.Overview
    • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.13.3.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.4.Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.14.Rest of APAC
    • 9.4.14.1.Overview
    • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.14.3.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.4.Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
• 9.5.Latin America
  • 9.5.1.Overview
  • 9.5.2.Liraglutide Key Manufacturers in Latin America
  • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.5.4.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.5.Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.5.6.Brazil
    • 9.5.6.1.Overview
    • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.6.3.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.4.Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.5.7.Mexico
    • 9.5.7.1.Overview
    • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.7.3.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.4.Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.5.8.Argentina
    • 9.5.8.1.Overview
    • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.8.3.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.4.Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.5.9.Colombia
    • 9.5.9.1.Overview
    • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.9.3.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.4.Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.5.10.Rest of LATAM
    • 9.5.10.1.Overview
    • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
• 9.6.Middle East and Africa
  • 9.6.1.Overview
  • 9.6.2.Liraglutide Key Manufacturers in Middle East and Africa
  • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.6.4.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.5.Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.6.6.Saudi Arabia
    • 9.6.6.1.Overview
    • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.6.7.United Arab Emirates
    • 9.6.7.1.Overview
    • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.6.8.Israel
    • 9.6.8.1.Overview
    • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.8.3.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.4.Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.6.9.Turkey
    • 9.6.9.1.Overview
    • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.9.3.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.4.Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.6.10.Algeria
    • 9.6.10.1.Overview
    • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.10.3.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.4.Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.6.11.Egypt
    • 9.6.11.1.Overview
    • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.11.3.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.4.Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.6.12.Rest of MEA
    • 9.6.12.1.Overview
    • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.12.3.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.4.Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Liraglutide Industry

• 10.1.Competitive Dashboard
• 10.2.Company Profiles
  • 10.2.1.Bachem
  • 10.2.2.HEC Pharm
  • 10.2.3.Kingpep Biotechnology
  • 10.2.4.Shenzhen JYMed Technology
  • 10.2.5.Novo Nordisk
  • 10.2.6.Eli Lilly and Company
  • 10.2.7.Boehringer Ingelheim
  • 10.2.8.AstraZeneca
  • 10.2.9.Others

11.360 Degree Analyst View

12.Appendix

• 12.1.Research Methodology
• 12.2.References
• 12.3.Abbreviations
• 12.4.Disclaimer
• 12.5.Contact Us